Effects of L-carnitine in patients with hepatic encephalopathy
Authors:
- Mariano MalaguarneraMMMariano Malaguarnera
- Giovanni PistoneGPGiovanni Pistone
- Rampello ElviraRERampello Elvira
- Carmelo LeottaCLCarmelo Leotta
- Linda ScarpelloLSLinda Scarpello
- Rampello LiborioRLRampello Liborio
Open Access
- 1 January 2005
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 11 (45) , 7197-7202
Abstract
Effects of L-carnitine in patients with hepatic encephalopathyKeywords
This publication has 30 references indexed in Scilit:
- Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathyHepatology, 1997
- Astrocytic-Ammonia Interactions in Hepatic EncephalopathySeminars in Liver Disease, 1996
- Changes in Distribution and Activity of Glutamine Synthetase in Carbon Tetrachloride–Induced Cirrhosis in the Rat: Potential Role in HyperammonemiaHepatology, 1994
- Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathyMetabolic Brain Disease, 1991
- Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic EncephalopathyJournal of Cerebral Blood Flow & Metabolism, 1991
- Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatmentBiochemical Medicine and Metabolic Biology, 1990
- Ammonia: Key factor in the pathogenesis of hepatic encephalopathyNeurochemical Pathology, 1987
- Carnitine deficiency and hyperammonemia associated with valproic acid therapyThe Journal of Pediatrics, 1982
- Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathyDigestive Diseases and Sciences, 1978
- Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathyDigestive Diseases and Sciences, 1977